Top 10 ASX Dividend Stocks for Nov 2026 Download Free Report

Healthcare

PYC Therapeutics (ASX:PYC): FY26 Results and Kidney Disease Clinical Developments

PYC Therapeutics Limited develops investigational RNA medicines for genetic diseases, using a proprietary delivery platform to bring therapeutic molecules into targeted cells. Its recent clinical disclosures focus on PYC-003 for polycystic kidney disease and other programs for inherited disorders affecting vision. On 26 October …

Aditi Sarkar | 26 October 2026

Ryman Healthcare (ASX:RYM): Retirement Village Resales, FY26 Results and Care Occupancy

Ryman Healthcare Limited operates retirement villages and aged care facilities across New Zealand and Australia, combining independent retirement living with assisted living and care services. On 26 October 2026, Ryman Healthcare (ASX:RYM) was quoted at AUD 1.455, down 1.02% for the trading session. The …

Aditi Sarkar | 26 October 2026

Regis Healthcare (ASX:REG): FY26 Results, Occupancy and Expansion Plans

Regis Healthcare Limited operates residential aged care homes and related care services across Australia, alongside home care, respite, day therapy and retirement living. Following its FY26 results, the group is progressing property developments and integrating acquired homes while responding to changing aged care funding …

Aditi Sarkar | 26 October 2026

Summerset Group Holdings (ASX:SNZ): 3Q26 Village Sales and Half-Year Performance

Summerset Group Holdings Limited develops and operates retirement villages and aged-care services in New Zealand and Australia, offering independent living and care options within its villages. Its October 2026 trading update reported 415 occupation-right sales for 3Q26, alongside higher year-to-date resales. On 26 October …

Aditi Sarkar | 26 October 2026

Nanosonics (ASX:NAN): FY26 Results, CORIS Launch Plans and FY27 Guidance

Nanosonics Limited develops infection-prevention technologies for medical device reprocessing, including its trophon ultrasound-probe disinfection systems and CORIS endoscope-reprocessing platform. On 26 October 2026, Nanosonics (ASX:NAN) was quoted at AUD 3.055, up 0.49% for the session. Its latest annual results outlined higher device placements, increased …

Aditi Sarkar | 26 October 2026

Integral Diagnostics (ASX:IDX): FY26 Financial Results and Medical Imaging Operations

Integral Diagnostics (ASX:IDX) delivers radiology and diagnostic imaging services, including magnetic resonance imaging (MRI), computed tomography (CT), ultrasound, X-ray and other specialist procedures. Its operations serve patients and referring clinicians in metropolitan and regional locations across Australia and New Zealand. The group operates through …

Aditi Sarkar | 26 October 2026

Cogstate (ASX:CGS): FY26 Results and 1QFY27 Clinical Trials Contract Update

Cogstate (ASX:CGS) operates in the measurement of cognition and central nervous system function. Its clinical trials business supplies digital tests, related scientific expertise, data quality processes and services used to assess participants in drug-development studies. Pharmaceutical sponsors employ these measures to collect consistent endpoint …

Aditi Sarkar | 26 October 2026

Clarity Pharmaceuticals (ASX:CU6): FY26 Results and SECuRE Trial Progress

Clarity Pharmaceuticals (ASX:CU6) is a clinical-stage business using its proprietary SAR technology to attach radioactive copper isotopes to targeting molecules. Copper-64 is employed for diagnostic positron emission tomography imaging, while copper-67 is being investigated for targeted therapy. The approach is intended to identify relevant …

Aditi Sarkar | 26 October 2026

PolyNovo (ASX:PNV): FY26 Revenue, NovoSorb Expansion and Manufacturing Progress

PolyNovo Limited develops and commercialises medical devices for burns and complex wounds using its NovoSorb technology platform. On 26 October 2026, PolyNovo (ASX:PNV) was quoted at AUD 0.845, down 3.98% for the session. Its FY26 financial statements show increased commercial sales and operating cash …

Aditi Sarkar | 26 October 2026

Imricor Medical Systems (ASX:IMR): U.S. Commercial Rollout and FDA Review Progress

Imricor Medical Systems (ASX:IMR) is based in Burnsville, Minnesota, and develops devices intended to support cardiac interventions performed under real-time magnetic resonance guidance. The approach gives clinicians MR imaging during procedures traditionally conducted using X-ray fluoroscopy. Its products comprise capital equipment, software and disposable …

Aditi Sarkar | 26 October 2026
Support

Hi! How can we help you today?

Loading…